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Abstract:  Intermediate  filaments  (IF)  are  essential  to  maintain  cellular  and  nuclear 
integrity and shape, to manage organelle distribution and motility, to control the trafficking 
and pH of intracellular vesicles, to prevent stress-induced cell death, and to support the 
correct distribution of specific proteins. Because of this, IF are likely to be targeted by a 
variety  of  pathogens, and  may  act  in favor  or  against  infection progress. As many  IF 
functions  remain  to  be  identified,  however,  little  is  currently  known  about  these 
interactions. Herpesviruses can infect a wide variety of cell types, and are thus bound to 
encounter  the  different  types  of  IF  expressed  in  each  tissue.  The  analysis  of  these 
interrelationships can yield precious insights into how IF proteins work, and into how 
viruses  have  evolved  to  exploit  these  functions.  These  interactions,  either  known  or 
potential, will be the focus of this review. 
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1. Introduction 
Intermediate filaments (IF) constitute the third main cytoskeletal system of vertebrate cells. They 
not  only  provide  structural  and  mechanical  support  to  the  cell,  but  are  also  involved  in  multiple 
cellular functions, including transport, protein and organelle targeting, migration, signaling, apoptosis, 
and protection from stress [1–4]. Because of this, IF are likely to play essential roles in enabling or 
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restricting  pathogen  infection,  and  have  the  potential  to  become  useful  targets  for  new  antiviral 
therapies. The dissection of IF-virus interactions could also provide crucial insights into the molecular 
mechanisms underlying the more than 80 human IF-linked diseases, and into the workings of cellular 
processes with the potential to be exploited therapeutically, such as the intracellular trafficking and 
delivery of cargoes. Compared to our knowledge of how viruses utilize the other two cytoskeletal 
components, the microfilaments (MF) and microtubules (MT), however, our current understanding of 
IF-virus interactions is largely incomplete. This review will focus on the interrelationships between 
human herpesviruses and IF during virion entry and egress, and during viral genome replication. 
1.1. IF: An Overview 
With an average diameter of 10 nm, IF owe their name to being of ―intermediate‖ size between MF 
(6 nm in diameter) and MT (25 nm in diameter). Numerous types of IF are formed by the assembly of 
different  polypeptides,  displaying  common  structural  domains  but  distinct  expression  profiles  
(Table 1). Because of their tissue-specific functions, the 70 currently known human IF proteins have 
been  associated  with  a  number  of  pathologies  affecting  various  organs  including  the  skin  
(e.g., epidermolysis bullosa simplex), the heart (e.g., dilated cardiomyopathy), the cornea (e.g., cataract), 
muscles (e.g., muscular dystrophy) and neurons (e.g., Charcot-Marie-Tooth disease) [4,5]. 
Table 1. Identity, tissue distribution and intracellular localization of intermediate filament 
(IF) family members. 
Type  Protein Name  Cell Type  Tissue Type 
I 
Acidic keratins:  
K9-K28 
K31-K40 
Epithelial cells, keratinocytes  Mucosae, epidermis 
Hair, epidermal appendages 
II 
Basic keratins:  
K1-8, K71-80 
K81-86 
Epithelial cells, keratinocytes 
Mucosae, epidermis 
Hair, epidermal appendages 
III 
Vimentin 
 
Peripherin 
Glial fibrillary acidic protein  
Syncoilin  
Desmin 
Mesenchymal cells: 
fibroblasts, endothelial, 
hematopoietic cells 
Neuronal cells 
Astrocytes and glia 
Muscle cells 
Connective tissue, blood, 
blood vessels 
Nervous system 
Nervous system 
Muscles 
IV 
-internexin 
Neurofilament H, L, and M  
Nestin  
Synemin , synemin  
Neuronal cells 
Neuronal cells 
Neuroepithelial cells 
Muscle cells 
Nervous system 
Nervous system 
Nervous system 
Muscles 
V  Lamin A, B1, B2, C1, C2  Ubiquitous  Ubiquitous 
VI 
CP49/phakinin, 
filensin/CP115 
Eye lens cells  Eye lens 
 
IF monomers consist of an alpha-helical rod flanked, at each end, by globular domains. Monomer 
dimerization is followed by the formation of tetramers via dimer association in antiparallel orientation, Viruses 2011, 3                         
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a setting that gives rise to smooth filaments devoid of polarity [6–8]. The polymerization of soluble, 
nucleotide-bound actin or tubulin, by contrast, generates polarized filaments possessing a plus end, to 
which subunits are added, and a minus end, from which subunits can be removed in a process known 
as treadmilling [9,10]. In contrast to MF and MT, IF assembly: (i) occurs spontaneously and in the 
absence of ATP or GTP [6–8,11]; (ii) does not depend on nucleotide availability or on the presence of 
cofactors  and  regulators,  albeit  new  proteins  facilitating  IF  polymerization  have  recently  been 
identified [12]; (iii) is primarily, although not exclusively, regulated by phosphorylation  [13]; and  
(iv) cannot be blocked by any currently available pharmaceutical compound.  
IF are durable, stable and remarkably more resistant to breakage than MF and MT [14]. Despite 
this, their intracellular networks are far from being static, and can quickly reorganize in response to a 
variety of extra- or intracellular stimuli. The molecular mechanisms at the basis of IF dynamics appear 
to depend on the kind of IF, the type of cell, and the specific intracellular location of filaments [8]. 
Lamin, vimentin and neurofilament polymerization, for instance, occurs at a slower rate than that of 
keratin [15], with the majority of nascent filaments moving in anterograde direction toward the cell 
surface. Keratin assembly, on the contrary, occurs principally at the cell periphery, and newly formed 
filaments are continually shifted toward the cell center [16]. The presence of intact MF and MT is 
required to support these movements, as transport of IF precursors relies on motor proteins associated 
with MT (kinesins and dyneins), and MF (myosins) [17–22]. All three cytoskeletal systems are thus 
largely interconnected, both functionally and physically. Vimentin IF and MT are tightly linked in 
human fibroblasts [23], with the pharmacological fragmentation of MT leading to the collapse of 
vimentin networks [17,23–25]. Bundling of vimentin IF by antibody injection, however, did not alter 
MT structure, indicating that MT-IF interactions are functionally unidirectional [26–28].  
Contrary to MF and MT, IF lack polarity and are not exploited as rails for intracellular transport. IF 
do,  however,  participate  in  a  variety  of  trafficking  events,  including  sorting  of  endo-lysosomes, 
mitochondria, and Golgi stacks [29], targeting of proteins to specific locations [29], and transmission 
of signals from the periphery to the nucleus for gene expression control [30]. IF are also crucial for 
proper shaping [31], positioning [32] and anchoring [33] of the nucleus, and to reduce the impact of 
mechanical and other types of stress on key cellular activities [13]. 
1.2. Human Herpesviruses and Their Tropisms 
Herpes  simplex  virus  1  and  2  (HSV-1  and  HSV-2),  varicella  zoster  virus  (VZV),  human 
cytomegalovirus (CMV), human herpesvirus-6 and -7 (HHV-6 and HHV-7), Epstein-Barr virus (EBV) 
and Kaposi’s sarcoma associated herpesvirus (KSHV) comprise the eight currently known human 
members of the Herpesviridae family (Table 2). All share a similar virion structure, consisting of a 
linear, double-stranded DNA molecule densely packaged into an icosahedral capsid, with a diameter 
of  115–130  nm.  The  capsid  is  surrounded  by  an  amorphous  protein  layer,  called  the  tegument, 
consisting of more than 30 proteins of viral and cellular origin, and by a lipid envelope containing 
approximately 10–12 viral glycoproteins plus a few cellular polypeptides [34]. Infectious virions are 
spherical, and measure approximately 200 nm in diameter. Viruses 2011, 3                         
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Table 2. Human herpesviruses and permissive cell types. 
Subfamily 
Virus 
Name 
Productive Infection  Latency 
Alpha 
HSV-1  Epithelial cells, neurons  Neurons: trigeminal ganglia 
HSV-2     
VZV  Epithelial cells, neurons, monocytes, 
dendritic cells, T and B lymphocytes 
Neurons: dorsal root ganglia 
Beta 
CMV  Most cell types except lymphocytes, 
eosinophils, basophils, and neutrophils 
Myeloid progenitors 
HHV-6  CD4+ T cells, neurons, astrocytes, 
microglia, fibroblasts, epithelial, 
endothelial and dendritic cells 
Lymphocytes, 
Monocyte/macrophages, other? 
HHV-7  CD4+ T cells   
Gamma 
EBV  B and T cells, dendritic, NK and 
smooth muscle cells 
Memory B cells 
KSHV  B cells, endothelial cells, epithelial 
cells, keratinocytes and fibroblasts 
 
All herpesviruses are species-specific, but the range of cell types and tissues they can infect w ithin 
each species varies widely. In vitro, HSV-1 and HSV-2 can enter most primary and established cells 
lines,  while  in  vivo  their  tropism  is  highly  restricted  to  the  epithelial  cells  of  the  oropharyngeal, 
respiratory and genital mucosae and to the innervating sensory neurons, where they establish latency 
[35,36]. In contrast to HSV, the range of cells permissive to VZV infection in vitro is extremely 
limited, whereas in vivo this virus can infect not only epithelial cells and neurons, but also monocytes, 
dendritic cells, and T and B lymphocytes [37].  
Almost  all  cell  types,  with  the  notable  exception  of  lymphocytes  and  polimorphonuclear 
leukocytes, are permissive to CMV infection in vivo [38]. Consequently, virtually all organs have been 
found to harbor replicating virus in acutely infected individuals [39,40]. Among permissive cell types, 
fibroblasts, epithelial, endothelial, smooth muscle and dendritic cells are particularly relevant to the 
development of disease, acting as sites of virus amplification, spread and immune evasion [38,39,41–45], 
while CD34
+ hematopoietic progenitors and monocytes are major reservoirs of latent virus [38,46].  
In vitro HHV-6 replicates most efficiently in activated CD4
+ lymphocytes, but can infect additional 
cell types including NK, liver, epithelial, endothelial and dendritic cells, fibroblasts, fetal astrocytes, 
and microglia [47]. In vivo, this virus is frequently detected in CD4
+ T cells and endothelial cells, 
brain and liver tissue, tonsils and salivary glands and, in latent form, in monocytes [47–49].  
Although B lymphocytes and epithelial cells are the main targets of EBV infection, numerous other 
cell types can be infected in vivo, including T lymphocytes, dendritic cells, NK and smooth muscle 
cells. KSHV’s tropism appears to be broader than that of EBV, both in vitro and in vivo, with B cells, 
endothelial cells, epithelial cells, keratinocytes and fibroblasts all capable of supporting production of 
viral progeny [50]. Both viruses establish lifelong latency in resting memory B cells [51]. 
Owing to their broad tissue tropism, herpesviruses are bound to encounter virtually all types of IF 
during  infection  in  vivo.  Despite  this,  our  current  knowledge  of  these  interactions  is  still  largely 
limited to just a few IF proteins.  Viruses 2011, 3                         
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2. Intermediate Filaments in Herpesvirus Entry 
Herpesviruses  replicate  their  genomes  in  the  nucleus.  To  start  productive  infection,  therefore, 
penetrated virions must be actively transported from the cell periphery to the nuclear compartment. 
This  is  accomplished  in  essentially  two  ways,  depending  on  the  virus  mode  of  entry  [52].  If 
penetration occurs by fusion of the viral envelope with the plasmalemma, ―naked‖ virions, i.e., capsids 
and tightly associated tegument proteins, are transported toward the nuclear envelope along cellular 
MT  [53–55].  If,  by  contrast,  viral  entry  occurs  by  endocytosis  or  macropinocytosis,  the  initial 
movement of virions toward the cell center takes place within cellular vesicles. Upon fusion of the 
viral envelope with vesicular membranes, capsids are then released into the cytosol, and reach the 
perinuclear space by associating, once again, with MT [36,51,52]. The long journey virions endure to 
enter host cells and reach the nucleus provides IF with numerous opportunities to support or hinder 
infection initiation (Figure 1).  
Figure  1.  Steps  during  herpesvirus  entry  that  may  require  intermediate  filaments’ 
assistance for efficient completion. IF and microtubules are shown as three parallel thin  
red  lines  and  as  thick  blue  lines,  respectively.  Black  hexagons  enclosed  in  a  circle  
depict  enveloped  virions,  while  isolated  black  hexagons  represent  virus  capsids.  
(A)  Keratin-type  IF  potentially  strengthening  initial  virion  interactions  with  the  cell 
surface; (B) enhancement of capsid attachment to microtubules via IF; (C) internalization 
of integrin-bound virions under the control of IF; (D) endosomes trafficking towards the 
cell  center  accompanied  by  IF;  (E)  AP-3  mediated  endosome  acidification  and  viral 
particles release facilitated by IF; (F) capsid movement along the nuclear envelope towards 
the nuclear pore complex assisted by IF; and (G) regulation of viral gene transcription 
onset by nuclear IF. MTOC, microtubule organizing center.  
 Viruses 2011, 3                         
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2.1. Virion Binding at the Cell Surface 
Natural transmission of herpesviruses occurs by contact between virions present in the bodily fluids 
of infected individuals and the oral or ano-genital mucosae of a new host. The epithelial cells and 
keratinocytes lining these openings express different types of keratins, while fibroblasts and endothelial 
cells in the underlying connective tissues contain vimentin. Both proteins can be exposed at the cell 
surface, where they may participate in cell-pathogen interactions.  
Keratins are deposited outside of the cell in specific areas of the mouth such as the hard palate, the 
gingiva, the tongue and the outer lip [56]. Their presence at these sites usually provides an effective 
barrier against pathogen invasion, although several bacteria were shown to use surface keratins as 
host-binding anchors [57–61]. Although the actual presence of non-keratin types of IF at the cell 
surface  is  still  under  debate  and  a  matter  of  controversy,  extracellular  exposure  of  vimentin  was 
reported  to  favor  attachment  and  internalization  of  viruses  such  as  the  porcine  reproductive  and 
respiratory  syndrome  virus  [62],  human  immunodeficiency  virus-1  [63],  and  Theiler’s  murine 
encephalomyelitis virus [64]. As the entry process of most herpesviruses, except EBV, begins with 
virion attachment to the ubiquitous heparan sulfate proteoglycans [65], surface keratins are unlikely to 
act  as  primary  sites  of  virion  binding  to  the  cell  surface,  although  a  role  for  these  proteins  in 
strengthening these initial virus-host contacts remains possible (Figure 1A). Primary HSV infection of 
the oral cavity generally occurs within non-keratinized tissues [66], and in an organotypic culture 
system mimicking stratified human epithelia, successful initiation of HSV-1 infection required virions 
to slip through microabrasions in the keratinized suprabasal layers of the epithelium [67]. At least for 
HSV, thus, keratins appear to hinder, rather than promote, virion entry. Whether surface vimentin 
plays any role in supporting initiation of herpesvirus infection, by contrast, remains to be determined. 
2.2. Virion Penetration 
All herpesviruses enter host cells by fusion of the viral envelope with cell surface or vesicular 
membranes, depending on the complement of proteins present on the virion and on the cell type [52]. 
CMV entry into epithelial and endothelial cells, for instance, occurs by macropinocytosis followed by 
capsids release in a low-pH-dependent [68,69] or independent [70,71] way, and requires the presence 
of the gH/gL/UL128/UL130/UL131A complex on the viral envelope [43,72,73]. CMV strains lacking 
this complex have a more limited tropism, and enter cells by fusion at the plasma membrane [38]. 
Engagement  of  cellular  vesicles  is  also  required  for  entry  of  HSV  into  epithelial  cells  such  as 
keratinocytes and HeLa cells, and of EBV into B cells, while penetration of HSV into fibroblasts, 
neurons and African green monkey kidney epithelial cells, and of EBV into primary human foreskin 
epithelial cells occurs by fusion at the cell surface [74–77]. 
All herpesviruses enter host cells by fusion of the viral envelope with cell surface or vesicular 
membranes. Irrespective of the mechanism used, herpesvirus entry usually leads to MF remodeling, 
accompanied  or  not  by  filament  disassembly,  while  the  structural  integrity  of  MT  is  generally 
maintained to support capsid transport toward the nucleus [78–87]. Currently available data also point 
at a remarkable conservation of IF networks [83–85,88,89], suggesting that the integrity of this system 
may be required for viral entry. In a recent work, we tested this hypothesis using human fibroblasts 
and two different CMV strains, one entering cells by fusion at the plasma membrane (AD169) [90] Viruses 2011, 3                         
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and  one  expected  to  enter  by  fusion  with  both  surface  and  vesicular  membranes  (TB40/E)  [83]. 
Penetration of both types of virions was severely impaired in cells where the vimentin cytoskeleton 
had been disrupted with acrylamide, a neurotoxin causing IF collapse in perinuclear aggregates [25]. 
Onset of infection was also delayed (AD169), and both delayed and reduced (TB40/E), by vimentin 
bundling in fibroblasts from patients with giant axonal neuropathy. Finally, the complete absence of 
this protein in vimentin
−/− mouse embryo fibroblasts deferred AD169 particle translocation across the 
cytosol,  and completely blocked progression of TB40/E virions  [83]. These results show that the 
presence of an intact vimentin network is required for CMV infection onset, and hint at a differential 
role for these IF in supporting virion progress toward the nucleus. Virion entry by fusion at the cell 
surface, indeed, appeared to be less dramatically affected by the absence of vimentin than entry by 
macropinocytosis, suggesting that vimentin’s role in managing intracellular vesicles’ movement may 
be more relevant to CMV infection than its scaffolding functions at the cell periphery.  
Whether other types of IF are required for viral entry in clinically-relevant cells like epithelial cells 
and neurons, and whether the presence of intact vimentin networks is also necessary for infection with 
other herpesviruses besides CMV remains to be determined. Also to be explored is the precise role 
played  by  IF  during  herpesvirus  entry,  a  task  complicated  by  the  fact  that  the  exact  function  of 
numerous  IF  proteins  has  not  yet  been  established.  Based  on  current  knowledge,  however,  the 
following possibilities may be envisaged: (i) being tightly connected with MT, some IF proteins might 
facilitate  binding  of  penetrated  capsids  to  MT  motor  proteins  at  the  cell  periphery  (Figure  1B);  
(ii) vimentin interacts with integrins 21, 64 and V3 at the cell surface, and mediates recycling 
of integrin-containing endocytic vesicles [91,92]. These IF could thus support entry of herpesviruses 
that use integrins as receptors, such as CMV [93–95], KSHV [96,97], and EBV [98], by enhancing the 
internalization  of  vesicles  containing  virion-integrin  complexes  (Figure  1C);  (iii)  vimentin  also 
accompanies endocytic vesicles in their migration toward the nucleus [99] and, together with the glial 
fibrillary acidic protein (GFAP), promotes the  directional mobility of vesicles in astrocytes  [100]. 
These functions could thus be exploited by endocytosed viral particles to traffic from the periphery to 
the center of the cell (Figure 1D). Vimentin’s role in stimulating clathrin uncoating from endocytic 
vesicles [101], by contrast, may not have an impact on infection onset, as herpesvirus virions are 
considered to be too large to fit into clathrin-coated endosomes, with the notable exception of KSHV 
[87,102];  (iv)  finally,  vimentin,  peripherin  and  -internexin  also  bind  to  AP-3  [103],  an  adaptor 
complex that regulates trafficking of vesicles in the endo-lysosomal compartment [104], maintains 
endo-lysosomal  stores  of  cellular  ionic  zinc  in  fibroblasts  [105],  and  controls  the  intracellular 
localization of the chloride channel ClC-3 [106], thus potentially contributing to influence lysosomal 
pH  [107,108].  In  the  absence  of  vimentin,  lysosomes  are  small,  do  not  properly  acidify,  and 
redistribute from their usual disperse cytoplasmic location to a juxtanuclear region [101,103]. Thus, at 
least in those instances where release of internalized capsids from cellular vesicles is pH-dependent 
[68,69,74,102,109,110],  the  presence  of  vimentin,  peripherin  or  -internexin  may  be  required  to 
induce the rapid acidification of endo-lysosomes via AP-3 (Figure 1E). Both vimentin and keratins, 
however, also appear to have a role in stimulating the formation of autophagosomes, as disruption of 
hepatic keratin networks completely inhibited autophagy [111], while vimentin
−/− cells were shown to 
contain lower number of autophagocytic vesicles than wild-type cells [103]. This specific IF function 
may  thus  favor  the  host,  rather  than  the  virus,  by  fostering  the  active  degradation  of  penetrated Viruses 2011, 3                         
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particles. Herpesviruses have indeed evolved a number of strategies to manipulate this cellular defense 
mechanism, although none have yet been reported to affect IF’s participation in this process [112]. 
2.3. Viral Genome Deposition into the Nucleus 
Dynein-bound  capsids  traveling  along  MT  [113]  are  thought  to  reach  the  MT-organizing  
center (MTOC), where most MT plus ends are anchored  [114]. This organelle is usually, but not 
always, located in proximity of the nucleus, at distances spanning from ~1.5 m in fibroblasts [115]  
to  5–10  m  in  neurons  [116].  Exactly  how  capsids  reach  the  nuclear  envelope  across  this  gap, 
corresponding to about 10- to 80-fold their average size, remains unclear. Although most capsids are 
initially located close to the MTOC, their distribution becomes more evenly dispersed around the 
nucleus at later times [117]. The precise mechanisms mediating this spread are also currently unknown.  
Electron microscopy imaging of HSV-1 and of murine gammaherpesvirus 68 entry into mammalian 
cells revealed that, once within 40 nm from the nuclear pore complex (NPC), capsids attach to the 
filaments  radiating  from  the  pore’s  outer  rim  [117,118].  This  binding  step  is  followed  by  the 
translocation of the viral genome from the capsid into the nucleus through the capsid portal and the 
NPC,  in  a  process  that  requires  energy  and  the  presence  of  cellular  proteins  other  than  those 
comprising the nuclear pore, and whose identity is currently unknown [119–121]. 
Cytoplasmic IF form cage-like webs around the nucleus, and can tightly associate with the nuclear 
envelope and with nuclear IF through a series of mediator proteins, including the recently discovered 
SUN  (Sad1  and  UNC-84)  and  KASH  (Klarsicht,  Anc-1  and  Syne/Nesprin  Homology)  family  
members [122–128]. Thus, nuclear lamins bind to SUN protein dimers located in the inner nuclear 
membrane (INM). These, in turn, interact with KASH domain-containing proteins residing in the outer 
nuclear membrane (ONM). One of these proteins, nesprin-3, then completes the link between the 
nucleus and the IF cytoskeleton by interacting with plectin, an IF-binding protein [129,130]. At least 
in the case of vimentin, this tight grip of IF on the nuclear envelope was shown to be essential for 
maintenance of a rounded nuclear shape [31], for anchoring of the nucleus within the cell [131], for 
force transfer from the periphery toward the cell center [132], and to prevent nuclear spinning [33]. By 
forming a crate of filaments surrounding the nuclear envelope, IF are likely to dock to the nuclear 
membrane at multiple locations. Thus, IF could potentially support not only the transfer of capsids 
from the MTOC to the nucleus, but also their spread along the nuclear envelope, in order to reach 
NPCs located at greater distances from the centrosome (Figure 1F). Evidence in favor of a role for 
vimentin in fostering uptake of HIV-1 preintegration complexes into the nucleus has indeed been 
provided [63].  
3. Intermediate Filaments in Herpesvirus Replication 
Following genome deposition into the nucleus, transcription of the viral immediate-early (IE) genes 
must occur to start productive viral replication, while their silencing is required to establish latency.  
Several lamina proteins were recently shown to participate in gene expression control by recruiting 
transcription factors and chromatin modifying enzymes to the nuclear periphery, thus leading to the 
formation of a transcriptionally repressive environment that is interrupted only in proximity of the 
nuclear pores [133]. For instance, while lamin A itself can inhibit gene expression when artificially Viruses 2011, 3                         
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tethered to promoters, [134], the lamina-associated protein 2 mediates transcriptional silencing by 
stimulating  histone  H4  deacetylation  after  binding  to  histone  deacetylase  3  [135].  The  lamin  B 
receptor protein (LBR), by contrast, supports heterochromatin anchoring to the nuclear envelope by 
interacting with the heterochromatin protein 1 and with deacetylated histones H3/H4 [136].  
Regularly spaced nucleosomes displaying the typical markers of heterochromatin are also usually 
associated with latent viral genomes maintained in episomal form within the nucleus of specific cells 
[137]. This transcriptionally silent status is reversed during reactivation bouts, possibly via reductions 
in the number of genome-associated histones, or via histone acetylation. Although a few viral and 
cellular  proteins  with  roles  in  controlling  these  events  have  already  been  identified,  a  number  of 
questions regarding the mechanisms and players involved in viral genome silencing during latency 
remain  open  [137].  Because  of  the  prominent  participation  of  the  nuclear  lamina  in  mediating 
transcriptional repression, nuclear IF are highly likely to be involved in viral latency establishment 
and/or maintenance, although this possibility has not yet been explored. By contrast, a role for lamin A 
in supporting the viral lytic replication cycle has been demonstrated  [138]. In the absence of this 
lamin, nascent replication compartments were no longer retained within transcriptionally active areas 
of the nucleus, leading to increased heterochromatinization of the viral genome, strong inhibition of IE 
protein expression, and markedly reduced viral yields [138].  
Other types of IF besides the lamins could also, potentially, be involved in herpesvirus replication 
events, on account of their involvement in intracellular signaling cascades [29]. Keratin mutation, 
GFAP overexpression and desmin downregulation were indeed shown to lead to changes in cellular 
gene  transcription  [29,139–141].  Theoretically,  thus,  these  IF  proteins  could  affect  viral  gene 
expression during both productive and latent life cycles (Figure 1G).  
Progression of herpesvirus infection is also associated with dramatic changes in transcription levels 
of numerous cellular genes, including those encoding IF proteins (Table 3). Although the relevance of 
these changes for viral replication has not been fully established, they are likely to contribute to the 
pathological  consequences  of  infection.  The  impact  of  VZV  infection  on  IF  gene  expression,  for 
instance, appears to be highly cell type-dependent, with the majority of changes observed in infected 
human skin implants in SCID mice (Table 3) [142]. In this tissue, transcription of numerous keratin 
genes was down-regulated, providing a possible molecular basis for the development of the typical 
skin  blisters  observed  in  patients  with  chickenpox.  Moreover,  the  concomitant  up-regulation  of 
vimentin expression may indicate the onset of epithelial-to-mesenchymal transitions. In contrast, CMV 
infection of fibroblasts appeared to induce the appearance of an opposite phenotype, with reductions in 
vimentin, syncoilin and keratin 19 expression, and induction of keratin 5, 13, 18, 85 and 86 synthesis 
[143]. CMV infection in human neural progenitor cells also leads to the marked down-regulation of 
GFAP expression, and to the skewing of these cells’ differentiation toward a nonneuronal lineage. 
Both events are likely to lead to the severe nervous system malformations observed in newborns with 
cytomegalic inclusion disease [144]. Finally, transcription of different keratin genes is also altered in 
tissues infected with EBV or KSHV [145–147], while expression of EBV LMP or EBNA4 proteins 
stimulated  expression  of  vimentin  [148–150],  but  the  significance  of  these  changes  for  viral 
pathogenesis is still unclear.  Viruses 2011, 3                         
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Table  3.  Changes  in  expression  levels  of  IF-encoding  genes  as  reported  in  functional 
genomics analyses of infected human tissues and fibroblasts (HF). 
Gene Name 
Gene 
Symbol 
VZV in 
T Cells * 
VZV in 
Skin * 
VZV in 
HF * 
HSV in 
HF 
& 
CMV in 
HF 
@ 
Keratin 1 
Keratin 5 
Keratin 6A 
Keratin 8 
Keratin 13 
Keratin 17 
Keratin 18 
Keratin 19 
Keratin 33A 
Keratin 71 
Keratin 85 
Keratin 86 
KRT1 
KRT5 
KRT6A 
KRT8 
KRT13 
KRT17 
KRT18 
KRT19 
KRT33A 
KRT71 
KRT85 
KRT86 
- 
- 
- 
- 
- 
- 
- 
- 
UP 
- 
- 
- 
DOWN 
DOWN 
DOWN 
- 
- 
DOWN 
- 
UP 
- 
DOWN 
- 
- 
- 
- 
UP 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
UP 
- 
- 
UP 
- 
- 
- 
- 
- 
- 
UP 
- 
- 
UP 
- 
UP 
DOWN 
- 
- 
UP 
UP 
Desmin 
Peripherin 
Syncoilin 
Vimentin 
DES 
PRPH 
SYNC 
VIM 
- 
- 
UP 
- 
UP 
- 
- 
UP 
- 
- 
- 
- 
- 
UP 
- 
DOWN 
- 
- 
DOWN 
DOWN 
Neurofilament 3 
Neurofilament heavy 
NEF3 
NEFH 
- 
DOWN 
DOWN 
- 
- 
- 
- 
- 
UP 
- 
Lamin B1  LMNB1  -  -  -  -  UP 
Data derived from the following references: 
* [142]; 
& [151,152]; 
@ [143]. 
4. Intermediate Filaments in Herpesvirus Egress 
After  being  filled  with  newly  replicated  viral  genomes,  nucleocapsids  leave  the  nucleus  by 
sequentially  budding  through  the  INM  and  ONM  in  the  so-called  envelopment-deenvelopment-
reenvelopment process, followed by the acquisition of tegument proteins and envelope  membranes 
from the trans-Golgi network and the ER in the cytoplasm. Mature virions are then incorporated into 
exocytic  vesicles  for  release  at  the  cell  surface  [153–155].  Once  again,  this  itinerary  provides 
herpesviruses with numerous opportunities to interact with a variety of IF proteins. 
4.1. Nucleocapsid Egress from the Nucleus 
Because of their size (115–130 nm), herpesvirus nucleocapsids cannot exit the nucleus through the 
NPC,  whose  functional  internal  diameter  measures  38  nm  in  size.  All  other  passageways  to  the 
cytoplasm necessarily entail crossing of the nuclear envelope, whose INM, however, is supported and 
protected by a dense IF network composed of A- and B-type lamins, and of their partners [156]. As 
destabilization of the nuclear lamina is required for capsids to reach the INM, all herpesviruses have 
been reported to induce changes in the structure and/or distribution of lamina components at late times 
post-infection. Although the exact mechanisms mediating these rearrangements are not completely 
understood, they are thought to depend, at least in part, on lamin phosphorylation events, similar to 
those leading to the dissolution of the nuclear envelope during mitosis [154]. Viruses 2011, 3                         
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At late times post-infection with HSV-1, the usually uniform distribution of lamin A/C and B at the 
nuclear rim becomes irregular and discontinuous. While a proportion of the lamin B and LBR proteins 
is relocated to a perinuclear cytoplasmic region, possibly corresponding to the ER [157,158], changes 
occurring to the lamin A/C proteins appear to be more conformational than positional [159]. Lamin 
A/C and B amounts were also reduced in infected COS-1 cells [157], while no change in lamin A/C 
and lamin-associated protein 2 levels were detected in infected Vero cells [160]. This suggests that 
degradation  of  lamina  components  is  cell  type-specific,  and  is  not  necessarily  required  for  its 
disruption. Both lamin B and the lamina-associated protein emerin are phosphorylated during infection 
[158,161], leading to the loss of connections between emerin and the nuclear membrane [162]. Lamin 
A/C is also phosphorylated on multiple sites by the viral kinases US3 and UL13, at least  in vitro 
[163,164]. Whether these phosphorylation events are sufficient to induce fragmentation of the lamina 
to the extent required for virions to access the INM is unknown. Expression of HSV-2 UL13 alone, 
however, was shown to almost completely recapitulate the changes in lamin A/C and B distribution 
observed in infected cells [164].  
According to the current model, the HSV nuclear egress complex (NEC) consists of the following 
components  [158–169]  (Figure  2,  left):  a  UL34-UL31  heterodimer,  anchored  to  the  INM  via  the 
transmembrane domain of UL34; the viral kinase UL13, which can phosphorylate US3, lamin A/C and 
lamin  B,  and  regulates  UL31  and  UL34  recruitment  to  the  INM;  the  viral  kinase  US3,  which 
phosphorylates UL34 and lamin A/C, but is not necessary for lamina disruption, and may instead 
function as a negative regulator of the process; PKC and PKC, which are recruited to the INM by 
the UL34-UL31 complex and are responsible for at least part of the observed phosphorylation of lamin 
A/C and B, and other, as yet unidentified, cellular kinases mediating emerin phosphorylation.  
Quite interestingly, although lamins constitute a formidable barrier to nucleocapsid egress from the 
nucleus, and could thus be considered negative regulators of infection, HSV-1 titers are decreased 
(instead of increased) by at least 10-fold in LmnB1
−/− murine fibroblasts lacking expression of lamin 
B1 [170]. This suggests that lamin B is required for efficient viral replication, possibly because of its 
function in gene transcription and DNA replication [171,172]. Finally, although rearrangement of the 
nuclear lamina is required for efficient replication, it is possible for nucleocapsids to leave the nucleus 
in the absence of these changes, as mutant viruses lacking expression of UL31 and UL34 can still 
replicate to some extent in non-complementing cells [166]. Intriguingly, the nuclei of cells infected 
with bovine herpesvirus 1 were shown to contain large gaps through which nucleocapsids could reach 
the cytoplasm without budding into nuclear membranes [173]. Although the existence of these gaps is 
still a matter of debate, their generation may involve different kinds of interaction with the lamina than 
those mediating its dissolution, potentially requiring the activity of an alternative set of viral proteins.  
CMV infection of human fibroblasts also profoundly modifies the structure of the lamina, inducing 
the appearance of deep INM invaginations that may favor capsid egress by acting as channels for the 
direct transport of virions towards the ONM [174–178]. The requirement for the presence of two viral 
proteins, M50 and M53, to achieve dissolution of the nuclear lamina was first demonstrated for murine 
CMV [179]. Their human CMV homologs, UL50 and UL53, were subsequently shown to be part of 
the CMV NEC (Figure 2, center), together with the viral kinase UL97, and the cellular proteins p32, 
LBR and PKC [180]. A new viral protein we just identified and named RASCAL also appears to 
localize to the NEC, likely through interactions with UL50  [82], while recruitment of the cellular Viruses 2011, 3                         
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peptidyl-prolyl cis/trans isomerase Pin1 to the nuclear rim was recently described to occur by binding 
to phosphorylated lamin A/C [181]. 
Figure  2.  Herpes simplex virus 1  (HSV-1), cytomegalovirus  (CMV) and Epstein-Barr 
virus (EBV) nuclear egress complex components and their interactions with the nuclear 
lamina. The two brown and thick lines represent the nuclear envelope, while the short 
black thin lines depict the lamin A/C and lamin B proteins comprising the nuclear lamina. 
Asterisks represent phosphorylation events performed by kinase proteins, whose names are 
contained in yellow-colored circles or ovals linked to the asterisks by orange arrows or 
arrowheads. The names of the two viral proteins composing the core of each nuclear egress 
complex (NEC) are contained within red- or orange-colored circles. 
 
 
How,  exactly,  the  nuclear  lamina  is  disassembled  during  CMV  infection  is  not  completely 
understood. The complete disappearance of lamin A/C at late times post-infection has been described 
in some [182,183], but not other [82,184,185] reports. Whether proteolytic degradation of this lamin 
occurs and, if so, how much it contributes to the whole disassembly process is therefore still uncertain. 
Also unclear is whether expression of UL50 and UL53 alone can support these changes as described 
in COS7 cells [184], or whether their main function is to recruit other NEC components including the 
kinases PKC and UL97, whose activity, by contrast, is absolutely required for lamina disassembly 
[179–182,185–187]. Because of its role in lamin A/C phosphorylation, UL97 has been proposed to act 
as a viral analog of the cellular cyclin-dependent kinase 1 (CDK1) [188], which supports dissolution 
of  the  nuclear  lamina  during  mitosis  [189].  Interestingly,  the  appearance  of  pathological  mitoses, 
characterized by the presence of multiple spindle poles and by the complete dissolution of the nuclear 
envelope, was observed to occur at late times post-infection with different strains of CMV, but in 
substantial amounts during infection with the fibroblast-adapted strain AD169 [190,191]. Pseudomitoses 
generation required the presence of CDK1, but the activity of this kinase was dispensable for the 
production  and  release  of  new  viral  particles  [191].  By  contrast,  the  simultaneous  inhibition  of 
multiple cyclin-dependent kinases, coupled or not to the inhibition of UL97, substantially reduced Viruses 2011, 3                         
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viral yields [191]. These results suggest that CMV may use a number of different cellular kinases, in 
addition to PKC and UL97, to support dissolution of the nuclear lamina during egress. Additionally, 
induction of pseudomitoses per se may represent an alternative method for CMV virions to leave the 
nucleus, since their presence in more than one quarter of infected cells did not have any negative effect 
on viral yields.  
Finally, not much is known about the impact of EBV or KSHV infection on the nuclear lamina. In 
striking contrast to HSV and CMV infection, which cause a dissociation of the INM and ONM, EBV 
infection induces duplications of the nuclear membrane [192]. These were generated by the activity of 
the viral protein BFRF1, which localizes at the nuclear rim, interacts with lamin B and recruits a 
second viral protein, BFLF2, a putative modulator of BFRF1 activity [193–195]. Similar to the alpha 
and beta herpesviruses, however, EBV also appears to encode a nuclear rim-localized kinase, BGLF4, 
which can induce lamina disassembly by lamin A/C phosphorylation [154,196] (Figure 2, right). 
4.2. Subviral Particle Trafficking from the Nucleus to the Cell Surface 
After leaving the ONM, nucleocapsids must cross the cytoplasm to reach the cell surface. During 
infection with a variety of viruses, this step is associated with IF disassembly, possibly to enhance the 
speed of capsid movement by reducing the viscosity of the cytoplasm. Infection of epithelial cells with 
HSV-1 was indeed shown to cause partial proteolysis of keratins [197], while keratin 17 phosphorylation 
by  HSV-2  US3  kinase  was  associated  with  reductions  in  these  IF’s  density  [198].  However, 
considering the complexity of herpesvirus maturation in the cytoplasm, a role for IF in supporting, 
instead of hindering, herpesvirus egress is far more likely.  
The interactions between vimentin, keratin and neurofilament IF and the Golgi apparatus [29], for 
instance, may be important for transfer of intracellular membranes to virions during their envelopment. 
In addition, desmin, keratins and neurofilaments are essential to maintain the correct morphology, 
distribution  and  function  of  mitochondria.  In  heart  and  skeletal  muscles  of  desmin-null  mice, 
mitochondria are misshapen and mislocalized, leading to a decrease in energy production and to the 
induction of apoptosis [199,200], while in neurons from patients with Charcot-Marie-Tooth disease 
caused by mutations in the neurofilament light subunit gene NF-L, mitochondria cluster close to the 
cell soma, leading to defects in axonal transport [201]. Through their interaction with mitochondria, 
thus, IF may support herpesvirus infection by securing an uninterrupted flow of energy, required to 
fuel viral genome synthesis and capsid transport. Also, IF may cooperate with viral anti-apoptotic 
proteins to prevent cell death. Finally, IF have a prominent role in targeting a variety of proteins to the 
plasma membrane [29], and in anchoring cells to each other as well as to the substratum by attaching 
to desmosomes and hemidesmosomes, respectively [202]. These functions could thus be exploited by 
maturing virions to promote the delivery of specific proteins to the sites of fusion between exocytic 
vesicles and the plasmalemma, and to target virion egress to the sites of cell-to-cell contact for lateral 
transmission within tissues. The NP protein of the lymphocytic choriomeningitis virus was indeed 
shown to promote intercellular spread of mature virions by binding to keratin 1 and stabilizing its 
filaments,  leading  to  the  establishment  of  stronger  cell-to-cell  contacts  that  favored  viral  
transmission [203]. A similar role for keratins and other types of IF can be easily envisaged during Viruses 2011, 3                         
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herpesvirus egress, particularly so in the case of HSV and VZV, whose transmission and pathological 
manifestations involve keratinized organs such as the skin.  
5. Concluding Remarks 
In summary, IF are highly dynamic structures whose role in cellular physiology is just starting to be 
unraveled. The analysis of their functions during herpesvirus infections is certain to provide exciting 
new insights into how key steps of the viral cycle are completed, and is likely to lead to potentially 
new avenues in the treatment of herpesvirus infections. 
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